Decentralized Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Decentralized Clinical Trials in Brazil

Decentralized Clinical Trials in Brazil – Clinical Trials in LATAM

Decentralized clinical trials (DCTs) have emerged as a groundbreaking approach to conducting medical research, transforming the traditional model by bringing trials directly to patients’ homes through the integration of technology. Brazil, with its vast population and robust healthcare system, presents a fertile ground for embracing DCTs and revolutionizing healthcare research.

In this blog, we will delve into the benefits, challenges, and potential of decentralized clinical trials in Brazil, shedding light on how this innovative approach can accelerate medical discoveries and improve patient outcomes.

Enhanced Accessibility and Inclusivity

Brazil’s vast size and diverse population make it an ideal setting for decentralized clinical trials. By eliminating the need for patients to travel long distances to research sites, DCTs significantly enhance accessibility, especially for individuals residing in remote areas or facing mobility challenges.

This patient-centric model promotes inclusivity by enabling a broader representation of the population to participate in research studies. By reaching underserved communities, decentralized trials have the potential to generate more diverse and representative data, leading to better-informed medical decisions.

Streamlined Participant Recruitment and Retention

Participant recruitment and retention pose significant challenges in traditional clinical trials. DCTs address these issues by leveraging technology to streamline these processes. Through telemedicine, remote monitoring devices, and mobile applications, researchers can engage with participants remotely, eliminating geographical and logistical barriers.

This streamlined approach enhances convenience for participants, potentially leading to higher enrollment and retention rates. By reducing the burden on participants and simplifying their involvement, DCTs have the potential to accelerate trial timelines and improve data quality.

Real-World Data and Ecological Validity

Decentralized clinical trials enable the collection of real-world data by conducting research within the participants’ natural environments. In Brazil, this approach offers valuable insights into how treatments and interventions perform in real-life scenarios.

By integrating digital health technologies like wearables and connected devices, researchers can gather continuous and comprehensive data on patient experiences, treatment adherence, and outcomes. This wealth of real-world data enhances ecological validity, enabling a more comprehensive evaluation of treatment efficacy and safety.

Regulatory Considerations and Collaboration

The success of decentralized clinical trials in Brazil relies on collaboration among various stakeholders, including researchers, healthcare providers, regulatory bodies, and technology providers. The Brazilian regulatory framework for clinical trials is evolving to accommodate innovative trial designs, emphasizing patient safety and data integrity.

Collaboration among stakeholders is crucial to establish standardized protocols, ethical guidelines, and regulatory processes specific to decentralized trials. By fostering partnerships and open communication, Brazil can create an environment conducive to the growth and adoption of decentralized trial models.

Decentralized Clinical Trials in Brazil

Decentralized Clinical Trials in Brazil

Decentralized Clinical Trials in Brazil

Digital Infrastructure and Technological Adoption

To unlock the full potential of decentralized clinical trials in Brazil, a robust digital infrastructure is essential. While Brazil has made significant progress in expanding its digital landscape, addressing gaps in internet connectivity and technological adoption is crucial.

Investments in telecommunication networks, digital literacy programs, and user-friendly interfaces are necessary to ensure equal access and engagement in decentralized trials. Additionally, comprehensive participant education programs can empower individuals to effectively navigate and utilize the technology employed in these trials.

Ethical Considerations and Informed Consent

Maintaining ethical standards and ensuring informed consent is paramount in decentralized clinical trials. In Brazil, researchers must ensure that participants fully understand the trial processes, risks, and benefits before providing informed consent.

Ethical considerations also encompass protecting participant privacy and safeguarding sensitive health data. Transparent communication, robust informed consent protocols, and stringent data protection measures are essential to address ethical concerns and build trust among participants in decentralized trials.

Cultural Diversity and Generalizability

Brazil is known for its cultural diversity, which presents an opportunity for decentralized clinical trials to capture a wide range of experiences and perspectives. By conducting trials in participants’ own environments, DCTs can provide insights into how treatments and interventions function across diverse cultural contexts.

This enhances the generalizability of research findings, ensuring that medical advancements are applicable to a broader population. By embracing decentralized trials, Brazil can contribute to global knowledge by providing data that represents its unique cultural and demographic landscape.

Patient Empowerment and Engagement

Decentralized clinical trials empower patients by placing them at the center of research. Participants have greater control over their involvement, benefiting from the convenience of remote data collection and reduced burden of travel. DCTs also facilitate continuous engagement through digital platforms, fostering a closer relationship between researchers and participants.

By actively involving patients in the research process, decentralized trials promote patient-centered care and amplify the voice of participants in shaping healthcare policies and decisions.

Overcoming Challenges and Building Infrastructure

While decentralized clinical trials offer immense potential, several challenges need to be addressed for successful implementation in Brazil. These include addressing disparities in digital infrastructure and connectivity, ensuring data privacy and security, and educating both researchers and participants on the benefits and proper use of technology.

Investments in technology infrastructure, capacity building, and collaborations with industry partners can help overcome these challenges and create an ecosystem where decentralized trials can flourish.


Decentralized clinical trials have the potential to revolutionize healthcare research in Brazil, fostering accessibility, inclusivity, and data collection. By leveraging technology, embracing collaboration, and addressing infrastructure gaps, Brazil can propel the adoption of decentralized trial models.

Through these innovative approaches, Brazil can accelerate medical discoveries, improve patient outcomes, and contribute to global advancements in healthcare. As Brazil embraces decentralized clinical trials, it positions itself as a leader in shaping the future of medical research, ultimately benefiting the health and well-being of its population and beyond.

Decentralized Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Decentralized Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Decentralized Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Decentralized Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Decentralized Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Decentralized Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Decentralized Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Decentralized Clinical Trials in Brazil

The Cohortias Team

Decentralized Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Decentralized Clinical Trials in Brazil

Network & Partnerships